Achieving breakthrough discoveries in small-molecule targeted therapeutics through expert integration of our unique biology insights, our cutting-edge technology platform, and globally networked operations
アリヴェクシス株式会社
Unveiling the Future of Medicine
Addressing previously difficult to approach biological targets through advanced structural analysis and cutting-edge supercomputing technologies
Accelerating delivery of therapeutic candidates from our portfolio of discovery programs to patients and families in need
Modulus Discovery, Inc. to Change Its Name to Alivexis, Inc. on March 11, 2024
